Global Deuterated Glucose Market Strategic Research Report

Scope of the Report

The global Deuterated Glucose market size is predicted to grow from US$ 30.47 million in 2025 to US$ 55.65 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032.

In 2025, global deuterated glucose production reached 259.58 kilograms, with an average selling price of US$120 per gram. The global annual production capacity of deuterated glucose is approximately 400 kilograms, and the gross profit margin is about 28.5%. Deuterated glucose refers to a compound obtained by substituting hydrogen atoms at specific positions (partially or fully) on natural glucose molecules with deuterium (a stable isotope of hydrogen, ²H or D), such as the commonly used glucose‑d6. Because deuteration alters the molecular mass and bond energy (C–D bonds are more stable than C–H bonds), deuterated glucose retains the original metabolic characteristics of glucose (e.g., entry into cells via glucose transporters) while offering lower background noise and a higher signal‑to‑noise ratio. It is therefore often used as a non‑radioactive molecular metabolic imaging tracer (e.g., in deuterium magnetic resonance metabolic imaging) or as a research reagent. The upstream sector of deuterated glucose includes deuterium sources, glucose precursors, and catalysts; the midstream sector comprises deuterated glucose manufacturers; and the downstream applications are primarily in tumour metabolism and imaging research, metabolic pathway and flux analysis, and analytical chemistry and quantitative detection.

As a deuterated compound, deuterated glucose has important applications in the pharmaceutical and medical imaging fields. The current market is in a period of rapid growth, but is constrained by high preparation costs and specific application scenarios, so the overall market size remains relatively niche. In the medical field, deuterated glucose is primarily used in deuterium magnetic resonance imaging (DMI) metabolic imaging. Owing to its advantages of being non‑radioactive and highly specific, it shows broad prospects in the early diagnosis of diseases such as tumours, which has driven demand at both the preclinical and clinical stages. In the research and industrial sectors, deuterated glucose serves as a high‑purity isotope‑labelled reagent and is widely used in drug metabolism studies and organic reaction mechanism analyses. At present, the pricing of deuterated glucose is relatively high, and is constrained by the purification costs of deuterated raw materials. The market is mainly concentrated among leading companies with high‑purity isotope preparation capabilities, as well as high‑end medical and research institutions. With the wider adoption of deuterated medical technologies, future market demand is expected to expand further.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Deuterated Glucose market?

What factors are driving Deuterated Glucose market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Deuterated Glucose market opportunities vary by end market size?

How does Deuterated Glucose break out by Type, by Application?

This report presents a comprehensive overview of the global Deuterated Glucose market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fully Deuterated Glucose
• Partially Deuterated Glucose
• Site-specific Deuterated Glucose

Segment by Abundance

• 95%–98%
• 98%–99%
• ≥99%

Segment by Craftsmanship

• Directly Deuterated Glucose
• Derivatized Deuterated Glucose

Segment by Application

• Tumor Metabolism and Imaging Research
• Metabolic Pathway and Flux Analysis
• Analytical Chemistry and Quantitative Detection
• Basic Biochemistry and Cellular Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Deuterated Glucose market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tumor Metabolism and Imaging Research, Metabolic Pathway and Flux Analysis, Analytical Chemistry and Quantitative Detection evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact